Quick Summary

Terminalia arjuna, commonly known as Arjuna, is a medicinal plant traditionally used in Indian medicine systems primarily for cardiovascular health. It contains bioactive compounds such as triterpenoids, flavonoids, and glycosides, which have been studied for their antioxidant, hypolipidemic, anti-inflammatory, and cardioprotective properties. Clinical evidence suggests moderate benefits in managing hypercholesterolemia and potential improvements in heart failure parameters, though the quality of evidence varies. Safety data indicate minimal adverse effects with short-term use, but long-term safety remains unclear. Current research supports cautious integration as a complementary option pending further rigorous clinical trials.

What Is It

Arjuna (Terminalia arjuna) is a deciduous tree native to India known for its bark, which is used as an herbal remedy. It has a long history of use in Ayurvedic medicine, particularly for supporting heart and cardiovascular health.

Traditional Uses

  • Support for heart health and cardiovascular function
  • Management of chest pain and angina
  • Use in traditional treatments for heart failure and hypertension
  • General tonic for promoting wellbeing

Active Compounds

Arjuna bark contains several bioactive constituents, including:

  • Triterpenoids
  • Flavonoids
  • Glycosides
  • Other antioxidants and phytochemicals

Potential Benefits with Evidence Levels

Cardiovascular Health Support (Moderate Evidence)

  • Dwivedi and Chopra 2014: Systematic review suggests anti-ischemic, antioxidant, hypolipidemic, and antiatherogenic activities with promising effects on ischemic cardiomyopathy.
  • Deng et al. 2025: Network meta-analysis reports significant efficacy in heart failure management by improving cardiac function indicators.
  • Srivastava et al. 2022: Randomized controlled trial found increased left ventricular ejection fraction and reduced fatigue in healthy adults with proprietary bark extract.
  • Gyawali et al. 2021: Meta-analysis shows moderate cholesterol-lowering effects of Ayurvedic herbs; although Arjuna was not the primary herb studied, related evidence suggests lipid profile benefits.
  • Amalraj and Gopi 2017: Review highlights antioxidant, hypotensive, anti-inflammatory, and cardioprotective properties in pharmacological studies.

Lipid Lowering Effect (Hypercholesterolemia Management) (Preliminary to Moderate Evidence)

  • Aravind et al. 2025: Systematic review protocol underway to clarify lipid-lowering effects of herbal interventions including Arjuna.
  • Gyawali et al. 2021: Identifies Ayurvedic herbs moderately effective in cholesterol reduction; Arjuna-specific data remain limited.

Anti-inflammatory and Antioxidant Effects (Preclinical and Limited Clinical Evidence)

  • Amalraj and Gopi 2017: Pharmacological studies document antioxidant, anti-inflammatory, and antiatherogenic activities attributed to flavonoids and triterpenoids.

Side Effects

Adverse effects appear minimal in available clinical trials. No serious adverse events have been directly attributed to Terminalia arjuna in short-term studies. However, comprehensive evaluation of rare or long-term adverse outcomes is lacking.

Drug Interactions

There is limited direct clinical data on drug interactions with Terminalia arjuna. Some evidence from studies on polyherbal formulations and extracts suggests potential interactions with cytochrome P450 enzymes, which could affect the metabolism of certain medications. Medical supervision is advised, especially when combined with cardiovascular or lipid-lowering drugs.

Who Should Avoid It

  • Individuals with known allergies or sensitivities to herbal products or complex formulations containing Arjuna
  • Pregnant or breastfeeding women due to insufficient safety evidence; use only under medical advice
  • People currently taking cardiovascular or lipid-lowering medications should consult a healthcare professional before use

Evidence Limitations

  • Many studies have methodological limitations such as small sample sizes, short duration, and variable design quality
  • Lack of large-scale, well-designed randomized controlled trials focused specifically on Terminalia arjuna
  • Variability in herbal preparations and dosing regimens complicates comparison and evidence synthesis
  • Limited data on long-term safety, pharmacokinetics, and herb-drug interactions
  • Most evidence comes from Indian traditional medicine context, limiting generalizability to other populations
  • Systematic reviews often include multiple herbs, making it difficult to isolate effects attributable solely to Arjuna

References

Last Reviewed

June 2024

Disclaimer: This page is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting any new herbal treatment or if you have questions regarding health conditions or medications.